Josh Claman, MBA, CEO of Rimidi, a healthcare technology company, discusses how and why technology such as remote patient monitoring and telehealth should be used to predict future outbreaks and serve as early warning systems for detecting viruses in individuals. He also talks about how to address minority health inequities exposed during COVID-19.
Josh Claman is a driven, experienced global executive. He has over 25 years leading technology businesses in Asia, Europe and the Americas. His industry experiences span his time at Dell in several senior executive positions, including the founding and development of Dell’s European Healthcare business, to his role as President of ReachLocal, one of the largest advertising technology companies in the US, and serving as the Chief Business Officer of Stratasys, a leader in 3D printing in the medical field. Josh is a strong advocate for the promise of technology.